Tuesday, March 6, 2018

Endo International plc (NASDAQ:ENDP) said it had obtained a preliminary injunction preventing privately-held QuVa Pharma Inc from marketing and releasing a compounded drug that could rival its blood pressure shot Vasostrict.

Endo International plc (NASDAQ:ENDP) wins injunction blocking ...

Benchmark Monitor-14 hours ago
Endo International plc (NASDAQ:ENDP) said it had obtained a preliminary injunction preventing privately-held QuVa Pharma Inc from marketing and releasing a compounded drug that could rival its blood pressure shot Vasostrict. The injunction was issued by U.S. District Judge Brian Martinotti in Trenton, New Jersey, ...
Post a Comment